Evidence map›Paper›PMID 26753760›Full record

ArticleJournal of leukocyte biology2016

TREM-like transcript 2 is stored in human neutrophil primary granules and is up-regulated in response to inflammatory mediators.

Kimberly A Thomas, R Glenn King, Christine M Sestero, Louis B Justement

Open access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The biology of TREM receptors.Nature reviews. Immunology · 2023
    Review
  5. International journal of molecular sciences · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Immunoreceptors on neutrophils.Seminars in immunology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kimberly A ThomasDepartment of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA;
R Glenn KingDepartment of Microbiology, University of Alabama at Birmingham, Alabama, USA; and.
Christine M SesteroDepartment of Biology, University of Montevallo, Alabama, USA.
Louis B JustementDepartment of Microbiology, University of Alabama at Birmingham, Alabama, USA; and lbjust@uab.edu.
University of Alabama at Birmingham · USUniversity of California, Los Angeles · USUniversity of Montevallo · US

Funding

ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
Identification and Analysis of the Physiological Ligand for TLT2R21AI107232 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JUSTEMENT, LOUIS B · 2013 to 2014
$391k
NIAID NIH HHS R21 AI107232NIAMS NIH HHS P30 AR048311
6 · The paper itself

Abstract

The triggering receptor expressed on myeloid cell locus encodes a family of receptors that is emerging as an important class of molecules involved in modulating the innate immune response and inflammation. Of the 4 conserved members, including triggering receptor expressed on myeloid cells 1 and 2 and triggering receptor expressed on myeloid cell-like transcripts 1 and 2, relatively little is known about triggering receptor expressed on myeloid cell-like transcript 2 expression and function, particularly in humans. In this study, experiments were performed to determine if triggering receptor expressed on myeloid cell-like transcript 2 expression is conserved between mouse and human, demonstrating that human triggering receptor expressed on myeloid cell-like transcript 2 is expressed on cells of the lymphoid, as well as myeloid/granuloid lineages, similar to murine triggering receptor expressed on myeloid cell-like transcript 2. Consistent with studies in the mouse, triggering receptor expressed on myeloid cell-like transcript 2 expression is up-regulated in response to inflammatory mediators on human neutrophils. Importantly, it was shown that triggering receptor expressed on myeloid cell-like transcript 2, in resting human neutrophils, is predominantly localized to intracellular vesicles, including secretory vesicles and primary granules; with the majority of triggering receptor expressed on myeloid cell-like transcript 2 stored in primary granules. In contrast to other primary granule proteins, triggering receptor expressed on myeloid cell-like transcript 2 is not expelled on neutrophil extracellular traps but is retained in the plasma membrane following primary granule exocytosis. In summary, these findings establish that triggering receptor expressed on myeloid cell-like transcript 2 expression is conserved between species and is likely to be important in regulating neutrophil antimicrobial function following primary granule exocytosis.

Indexed as

Cells, CulturedGene Expression RegulationHumansImmunity, InnateInflammationInflammation MediatorsNeutrophilsReceptors, ImmunologicSecretory VesiclesInflammation MediatorsReceptors, ImmunologicTREML2 protein, humanexocytosisleukocyteTLT2

Identifiers

PMID26753760
PMCPMC6608082
OpenAlexW2236347406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.